XRCC2 and non-small cell lung carcinoma: Further bioinformatics analysis revealed FANCI, MSH2, XRCC2, and FANCD2 were positively coexpressed with PAICS (Figures 7E and F), and the upregulated expression of them was significantly associated with a poorer prognosis in NSCLC (Figure 7G).